| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/26/2014 | CN102579700B Medicinal liquor for treating arthritis |
| 02/26/2014 | CN102579558B Application of bauhinia championii general flavone in preparation of medicament for treating rheumatoid arthritis |
| 02/26/2014 | CN102579344B Losartan potassium liposome solid preparation |
| 02/26/2014 | CN102558187B Tetrahydroporphin compound and preparation method and application thereof |
| 02/26/2014 | CN102558032B Amorphous lercanidipine hydrochloride and preparation method thereof |
| 02/26/2014 | CN102552605B Tibetan veterinary medicament for detoxifying and removing necrotic tissues |
| 02/26/2014 | CN102552467B Chinese medicinal preparation for treating coronary heart disease and preparation method thereof |
| 02/26/2014 | CN102552113B Ethacridine lactate ointment as well as preparation method and application thereof |
| 02/26/2014 | CN102552107B Two-phase release preparation containing zolpidem or salt of zolpidem and preparation method thereof |
| 02/26/2014 | CN102531999B Amorphous lercanidipine hydrochloride and preparation method thereof |
| 02/26/2014 | CN102526146B Medicament composition containing ginsenoside and cantharidin and application of medicament composition |
| 02/26/2014 | CN102516237B Oxazolidinone derivative |
| 02/26/2014 | CN102512496B White flower danshen total phenanthrenequinone extract for treating angiitis, medicinal composition and preparation method |
| 02/26/2014 | CN102503951B Garcinia derivative and preparation method and medicinal application thereof |
| 02/26/2014 | CN102481286B Antimycotic pharmaceutical composition |
| 02/26/2014 | CN102471317B Aminopyridine derivatives for treating tumors and inflammatory diseases |
| 02/26/2014 | CN102470131B Fentanyl-containing adhesive preparation for external use |
| 02/26/2014 | CN102458368B Solid pharmaceutical preparations containing copolymers based on polyethers combined with poorly water-soluble polymers |
| 02/26/2014 | CN102417479B STAT3 small molecular selective inhibitor and preparation method and application thereof |
| 02/26/2014 | CN102382129B Spirocycles-substituted phosphodiesterase inhibitor |
| 02/26/2014 | CN102372692B 二氢吡啶衍生物 Dihydropyridine derivatives |
| 02/26/2014 | CN102362877B Application of Pouzolzia extract |
| 02/26/2014 | CN102349915B Acetaminophen, caffeine, chlorphenamine maleate, and vitamin C preparation and preparation method thereof |
| 02/26/2014 | CN102340991B Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye |
| 02/26/2014 | CN102335134B Clevidipine butyrate liquid liposome preparation |
| 02/26/2014 | CN102267888B Chalcone derivative preparation method |
| 02/26/2014 | CN102229580B Novel pleuromutilin derivate, preparation method and medical use thereof |
| 02/26/2014 | CN102174044B Tetomilast polymorphs |
| 02/26/2014 | CN102165950B Bacteriostatic and bactericidal activity of phenylglycine derivative on escherichia coli |
| 02/26/2014 | CN102131810B Diketone fused azolopiperidines and azolopiperazines as anti-HIV agents |
| 02/26/2014 | CN102118976B Nutritional composition for infants delivered via caesarean section |
| 02/26/2014 | CN102099352B STAT3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 02/26/2014 | CN102050831B Cephalosporin derivative |
| 02/26/2014 | CN102036961B Pyridines and pyrazines as inhibitors of PI3K |
| 02/26/2014 | CN101918407B Beta-lactamase inhibitors |
| 02/26/2014 | CN101837125B Method of regulating phosphorylation of PTH protein and antiviral agents comprising SR protein activity regulator as the active ingredient |
| 02/26/2014 | CN101687802B Benzenesulfonamide compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 02/26/2014 | CN101671301B Heterocyclic substituent acardite derivate and application thereof |
| 02/26/2014 | CN101627073B Imprinted polymers |
| 02/26/2014 | CN101583360B Tamper resistant oral pharmaceutical dosage forms comprising an opioid analgesic |
| 02/26/2014 | CN101547689B Tetra-substituted ndga derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use |
| 02/26/2014 | CN101518528B Application of carbocyanine dye near infrared fluorescent compound |
| 02/26/2014 | CN101472888B Optical pure chromocor derivate for treating proliferative lesion and preparation method thereof |
| 02/26/2014 | CN101455649B Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 02/26/2014 | CN101203515B Pyrido[2,3-d]pyrimidines used as HCV inhibitors, and methods for the preparation thereof |
| 02/26/2014 | CN101003573B Human antibodies that bind human tnfalpha |
| 02/25/2014 | US8658838 Series of skin whitening (lightening) compounds |
| 02/25/2014 | US8658821 Process for the preparation of nateglinide |
| 02/25/2014 | US8658809 Process for the preparation of dronedarone |
| 02/25/2014 | US8658799 Process for the preparation of crystalline modifications for use in the preparation of esomeperazole sodium salt |
| 02/25/2014 | US8658797 Asymmetric ureas and medical uses thereof |
| 02/25/2014 | US8658791 2-substituted-6-amino-5-alkyl, alkenyl or alkynyl-4-pyrimidinecarboxylic acids and 6-substituted-4-amino-3-alkyl, alkenyl or alkynyl picolinic acids and their use as herbicides |
| 02/25/2014 | US8658787 Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease |
| 02/25/2014 | US8658710 Oxidation-resistant and wear-resistant polyethylenes for human joint replacements and methods for making them |
| 02/25/2014 | US8658703 Aqueous suspension preparations |
| 02/25/2014 | US8658701 Foaming alcohol compositions with selected dimethicone surfactants |
| 02/25/2014 | US8658700 Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine |
| 02/25/2014 | US8658699 Chemical permeation enhancers enhance nerve blockade by toxins |
| 02/25/2014 | US8658697 Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses |
| 02/25/2014 | US8658695 Disodium salts, monohydrates, and ethanol solvates for delivering active agents |
| 02/25/2014 | US8658694 Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same |
| 02/25/2014 | US8658693 4-aminobenzonitrile selective androgen receptor modulators |
| 02/25/2014 | US8658691 Crystalline forms of a 3-[2-methanesulfonyl-1-(4-trifluoromethyl-phenoxy)ethyl]pyrrolidine compound |
| 02/25/2014 | US8658690 Use of novel compounds from fruiting body of Antrodia camphorata for treating an inflammatory disorder |
| 02/25/2014 | US8658689 Heterocyclic inhibitors of necroptosis |
| 02/25/2014 | US8658687 Injectable formulations containing asenapine and method of treatment using same |
| 02/25/2014 | US8658686 Pyrazole compounds having therapeutic effect on multiple myeloma |
| 02/25/2014 | US8658685 Methods for treatment of kallikrein-related disorders |
| 02/25/2014 | US8658684 Pharmaceutical composition and its use in the preparation of a medicament for the treatment of cerebrovascular diseases |
| 02/25/2014 | US8658683 Combination of alpha-2 receptor agonist (clonidin) and anti-muscarinic agent (oxybutynin) for the treatment of sialorrhoea |
| 02/25/2014 | US8658682 (E)-1-(4-((1R,2S,3R)-1,2,3,4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone dihydrate and methods of its use |
| 02/25/2014 | US8658681 Treatment of hyperproliferative disorders with diarylhydantoin compounds |
| 02/25/2014 | US8658680 Chemically stable dispersions of prothioconazole and processes for preparing them |
| 02/25/2014 | US8658678 Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water |
| 02/25/2014 | US8658677 Pyridyl-2-methylamino compounds, compositions and uses thereof |
| 02/25/2014 | US8658676 Clevidipine emulsion formulations containing antimicrobial agents |
| 02/25/2014 | US8658674 Thiophene analogues for the treatment or prevention of flavivirus infections |
| 02/25/2014 | US8658673 BETA2-adrenoreceptor agonists |
| 02/25/2014 | US8658672 HIF-1α activating agent |
| 02/25/2014 | US8658671 Crystalline form of a quinolinone-carboxamide compound |
| 02/25/2014 | US8658670 Methods and compounds for treatment of clostridium based infection |
| 02/25/2014 | US8658669 Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors |
| 02/25/2014 | US8658668 PI3 kinase/mTOR dual inhibitor |
| 02/25/2014 | US8658667 Stable formulations, and methods of their preparation and use |
| 02/25/2014 | US8658666 Substituted imidazoquinolines and imidazonaphthyridines |
| 02/25/2014 | US8658665 3,6-disubstituted xanthylium salts and use thereof in treatment of tauopathies |
| 02/25/2014 | US8658664 Cyclopamine tartrate salt and uses thereof |
| 02/25/2014 | US8658663 Method of treating thermoregulatory disfunction with paroxetine |
| 02/25/2014 | US8658662 Crystalline CDC7 inhibitor salts |
| 02/25/2014 | US8658661 Oxadiazole inhibitors of leukotriene production |
| 02/25/2014 | US8658660 5-fluoro-4-imino-3,4-dihydropyrimidin-2-(1H)-ones derivatives |
| 02/25/2014 | US8658658 Compound, certain novel forms thereof, pharmaceutical compositions thereof and methods for preparation and use |
| 02/25/2014 | US8658657 2-aminopyrimidin-4-one and 2-aminopyridine derivatives both having BACE1-inhibiting activity |
| 02/25/2014 | US8658656 Methods and compositions utilizing quinazolinones |
| 02/25/2014 | US8658655 Inhibition of activated cdc42-associated kinase 1 |
| 02/25/2014 | US8658654 Receptor-type kinase modulators and methods of use |
| 02/25/2014 | US8658653 Inhibitors of Bruton's tyrosine kinase |
| 02/25/2014 | US8658652 Antifolate combinations |
| 02/25/2014 | US8658651 Compounds that are ERK inhibitors |
| 02/25/2014 | US8658650 Substituted 1,1,3,1-tetraoxidobenzo[D][1,3,2]dithiazoles as MGLUR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |